These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32800318)

  • 21. Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?
    Luk CP; Parsons R; Lee YP; Hughes JD
    Ann Pharmacother; 2013 Jun; 47(6):773-80. PubMed ID: 23632281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe hypomagnesemia during long-term treatment with a proton pump inhibitor.
    Regolisti G; Cabassi A; Parenti E; Maggiore U; Fiaccadori E
    Am J Kidney Dis; 2010 Jul; 56(1):168-74. PubMed ID: 20493607
    [No Abstract]   [Full Text] [Related]  

  • 23. Tetany, hypomagnesemia, and proton-pump inhibitors.
    Famularo G; Minisola G; Bravi MC; Colucci P; Gasbarrone L
    Am J Med; 2012 Oct; 125(10):e7-8. PubMed ID: 22800870
    [No Abstract]   [Full Text] [Related]  

  • 24. Torsade de pointes and long QT syndrome following major blood transfusion.
    Kulkarni P; Bhattacharya S; Petros AJ
    Anaesthesia; 1992 Feb; 47(2):125-7. PubMed ID: 1539780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use.
    Chowdhry M; Shah K; Kemper S; Zekan D; Carter W; McJunkin B
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1717-1721. PubMed ID: 29514412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [An unknown but potentially serious side effect of proton pump inhibitors: hypomagnesaemia].
    Doornebal J; Bijlsma R; Brouwer RM
    Ned Tijdschr Geneeskd; 2009; 153():A711. PubMed ID: 19930736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnesium Deficiency and Proton-Pump Inhibitor Use: A Clinical Review.
    William JH; Danziger J
    J Clin Pharmacol; 2016 Jun; 56(6):660-8. PubMed ID: 26582556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Severe heart arrhythmia secondary to magnesium depletion. Torsade de pointes].
    Papaceit J; Moral V; Recio J; de Ferrer JM; Riva J; Bayés de Luna A
    Rev Esp Anestesiol Reanim; 1990; 37(1):28-31. PubMed ID: 2326522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton pump inhibitors and severe hypomagnesaemia.
    Cundy T; Mackay J
    Curr Opin Gastroenterol; 2011 Mar; 27(2):180-5. PubMed ID: 20856115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of hypomagnesemia.
    Ayuk J; Gittoes NJ
    Am J Kidney Dis; 2014 Apr; 63(4):691-5. PubMed ID: 24100128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypomagnesemia Following Prolonged Use of Proton-pump Inhibitors.
    Janett S; Bianchetti MG; Milani GP; Lava SA
    J Pediatr Gastroenterol Nutr; 2016 Apr; 62(4):e39. PubMed ID: 27010402
    [No Abstract]   [Full Text] [Related]  

  • 32. Hypomagnesemia and proton pump inhibitors: below the tip of the iceberg.
    Furlanetto TW; Faulhaber GA
    Arch Intern Med; 2011 Aug; 171(15):1391-2. PubMed ID: 21555654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Prevalence of Hypomagnesemia in Hospitalized Type 2 Diabetic Patients Treated with Diuretics and/or Proton Pump Inhibitors.
    Mengesha B; Levi D; Kroonenberg M; Koren R; Golik A; Koren S
    Isr Med Assoc J; 2021 Apr; 23(4):245-250. PubMed ID: 33899358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations.
    Snitker S; Doerfler RM; Soliman EZ; Deo R; St Peter WL; Kramlik S; Fischer MJ; Navaneethan S; Delafontaine P; Jaar BG; Ojo A; Makos GK; Slaven A; Weir MR; Zhan M; Fink JC;
    Clin J Am Soc Nephrol; 2017 Sep; 12(9):1409-1417. PubMed ID: 28793999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypomagnesaemia due to use of proton pump inhibitors--a review.
    Kuipers MT; Thang HD; Arntzenius AB
    Neth J Med; 2009 May; 67(5):169-72. PubMed ID: 19581665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton pump inhibitor use for 12 months is not associated with changes in serum magnesium levels: a prospective open label comparative study.
    Bahtiri E; Islami H; Hoxha R; Gashi A; Thaçi K; Karakulak Ç; Thaçi S; Qorraj Bytyqi H
    Turk J Gastroenterol; 2017 Mar; 28(2):104-109. PubMed ID: 28082254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton pump inhibitors and hypomagnesemia in patients with arrhythmias.
    Ragupathi L; Fonseka N; Sendecki JA; McCarey MM; Breecker SW; Whellan DJ
    Int J Clin Pract; 2015 Dec; 69(12):1525-6. PubMed ID: 26647010
    [No Abstract]   [Full Text] [Related]  

  • 38. Proton pump inhibitors and symptomatic hypomagnesemic hypoparathyroidism.
    Fatuzzo P; Portale G; Scollo V; Zanoli L; Granata A
    J Nephrol; 2017 Apr; 30(2):297-301. PubMed ID: 27206762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diuretic-induced potassium and magnesium deficiency: relation to drug-induced QT prolongation, cardiac arrhythmias and sudden death.
    Singh BN; Hollenberg NK; Poole-Wilson PA; Robertson JI
    J Hypertens; 1992 Apr; 10(4):301-16. PubMed ID: 1316396
    [No Abstract]   [Full Text] [Related]  

  • 40. The Relationship Between Resistant Tachycardia and Treatment for GERD.
    Elliott EM
    Explore (NY); 2016; 12(6):456-458. PubMed ID: 27693368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.